Family · Pharmaceutical analytical standards
Milnacipran
An antidepressant that inhibits the reuptake of serotonin and noradrenaline (SNRI), first approved in France in December 1996 for major depression. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?In the United States its story is different: the FDA approved it in 2009 only for fibromyalgia, a widespread pain syndrome, and not for depression.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
